Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2020-21) and Update on Immunization for Children Aged 0 Through 18 Years.


Journal

Indian pediatrics
ISSN: 0974-7559
Titre abrégé: Indian Pediatr
Pays: India
ID NLM: 2985062R

Informations de publication

Date de publication:
15 01 2021
Historique:
pubmed: 2 12 2020
medline: 20 8 2021
entrez: 1 12 2020
Statut: ppublish

Résumé

In view of new developments in vaccinology and the availability of new vaccines, there is a need to revise/review the existing immunization recommendations. Advisory Committee on Vaccines and Immunization Practices (ACVIP) of Indian Academy of Pediatrics (IAP) had a physical meeting in March, 2020 followed by online meetings (September-October, 2020), to discuss the updates and new recommendations. Opinion of each member was sought on the various recommendations and updates, following which an evidence-based consensus was reached. To review and revise the IAP recommendations for 2020-21 and issue recommendations on existing and new vaccines. The major changes include recommendation of a booster dose of injectable polio vaccine (IPV) at 4-6 years for children who have received the initial IPV doses as per the ACVIP/IAP schedule, re-emphasis on the importance of IPV in the primary immunization schedule, preferred timing of second dose of varicella vaccine at 3-6 months after the first dose, and uniform dosing recommendation of 0.5 mL (15 µg HA) for inactivated influenza vaccines.

Identifiants

pubmed: 33257602
pii: S097475591600258
pmc: PMC7840391
pii:

Substances chimiques

Chickenpox Vaccine 0
Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-53

Références

J Infect Dis. 2021 Jan 4;223(1):113-118
pubmed: 32621746
J Pediatric Infect Dis Soc. 2017 Mar 01;6(1):9-19
pubmed: 28062552
Pediatr Infect Dis J. 2011 Dec;30(12):1081-5
pubmed: 21983214
Vaccine. 2015 Aug 26;33(36):4579-85
pubmed: 26165918
Lancet Child Adolesc Health. 2018 May;2(5):338-349
pubmed: 30169267
J Infect Dis. 1976 Dec;134(6):633-8
pubmed: 794423
J Infect Dis. 1995 Jul;172(1):217-9
pubmed: 7797914
Vaccine. 2010 Jun 17;28(27):4376-83
pubmed: 20447477
Am J Surg Pathol. 2015 Jun;39(6):802-12
pubmed: 25871617
Clin Infect Dis. 2021 Nov 2;73(9):e2722-e2728
pubmed: 32556113
J Infect Dis. 1995 Jan;171(1):13-7
pubmed: 7798653
N Engl J Med. 2007 Mar 15;356(11):1121-9
pubmed: 17360990
JAMA. 2004 Feb 18;291(7):851-5
pubmed: 14970064
Pediatrics. 1997 Nov;100(5):761-6
pubmed: 9346974
Vaccine. 2018 Sep 5;36(37):5500-5503
pubmed: 30107991
Wkly Epidemiol Rec. 2015 Dec 11;90(50):681-99
pubmed: 26685390
J Infect Dis. 2019 Jul 2;220(3):386-391
pubmed: 30869149
Vaccine. 2010 Nov 23;28(50):7865-72
pubmed: 20943209
Vaccine. 2020 Jan 10;38(2):399-410
pubmed: 31843266
Vaccine. 2007 Sep 17;25(37-38):6655-60
pubmed: 17706845
Vaccine. 2009 Jan 7;27(2):179-80
pubmed: 19007837
Pediatr Infect Dis J. 1996 Jan;15(1):49-54
pubmed: 8684876
J Infect Dis. 2005 Mar 15;191(6):990-9
pubmed: 15717277
Indian Pediatr. 2014 Oct;51(10):785-800
pubmed: 25362009
Hum Vaccin. 2010 Feb;6(2):189-93
pubmed: 20009522
Indian J Pediatr. 2020 Nov;87(11):974-988
pubmed: 33047253
Am J Epidemiol. 1969 Aug;90(2):146-56
pubmed: 4308600
J Infect Dis. 2014 Nov 1;210 Suppl 1:S475-84
pubmed: 25316870
Indian Pediatr. 2018 Dec 15;55(12):1066-1074
pubmed: 30745480
Pediatrics. 2013 May;131(5):e1389-96
pubmed: 23545380
Int J Infect Dis. 2015 Sep;38:36-42
pubmed: 26166699
Clin Infect Dis. 2009 Jul 1;49(1):e1-10
pubmed: 19476428
Pediatr Infect Dis J. 2004 Feb;23(2):132-7
pubmed: 14872179
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):784-789
pubmed: 32584798
Pediatr Infect Dis J. 2005 Aug;24(8):665-9
pubmed: 16094217
Pediatrics. 1985 Apr;75(4):667-71
pubmed: 2984636
Hum Vaccin Immunother. 2019;15(3):645-657
pubmed: 30427766
Vaccine. 2004 Mar 29;22(11-12):1406-14
pubmed: 15063563
Pediatr Infect Dis J. 2010 Aug;29(8):690-3
pubmed: 20216242
Pediatrics. 2011 Aug;128(2):e276-89
pubmed: 21768314
Vaccine. 2004 Mar 29;22(11-12):1415-22
pubmed: 15063564
Pediatr Infect Dis J. 2019 Mar;38(3):323-328
pubmed: 30395011
Vaccine. 2006 Mar 20;24(13):2440-8
pubmed: 16406224

Auteurs

Srinivas G Kasi (SG)

Kasi Clinic, Jayanagar, Bengaluru, Karnataka, India. Correspondence to: Srinivas G Kasi, Convener, ACVIP, Kasi Clinic, 2nd Cross, 3rd Block, Jayanagar, Bengaluru 560011, Karnataka, India. sgkasi@gmail.com.

S Shivananda (S)

Fortis Hospital, Banneraghatta Road, Bengaluru, Karnataka, India.

Sanjay Marathe (S)

Marathe Child Care Hospital, Nagpur, India.

Kripasindhu Chatterjee (K)

Department of Pediatrics, Gouri Devi Institute of Medical Science and Hospital, Durgapur, Paschim Bardhaman, West Bengal, India.

Sunil Agarwalla (S)

Department of Pediatrics, MKCG MCH, Berhampur, Odisha, India.

Shashi Kant Dhir (SK)

Department of Pediatrics, Guru Gobind Singh Medical College, Faridkot, Punjab, India.

Sanjay Verma (S)

Division of Infectious Diseases, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Abhay K Shah (AK)

Dr Abhay K Shah Children Hospital, Ahmedabad, Gujarat, India.

Sanjay Srirampur (S)

Department of Pediatrics, Aditya Super speciality Hospital, Hyderabad, Telangana, India.

Srinivas Kalyani (S)

Department of Pediatrics, Niloufer Hospital, Osmania medical College, Hyderabad, India.

Harish Kumar Pemde (HK)

Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India.

S Balasubramanian (S)

Department of Pediatrics, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu, India.

Bakul J Parekh (BJ)

Bakul Parekh Hospital for Children, Mumbai, India.

G V Basavaraja (GV)

Department of Pediatrics, IGICH, Bengaluru, Karnataka, India.

Piyush Gupta (P)

Department of Pediatrics, University College of Medical Sciences, New Delhi; India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH